Haiyan Jiang Selected Research

serine racemase

1/2022	Alterations of serine racemase expression determine proliferation and differentiation of neuroblastoma cells.
1/2021	Overexpression of D-amino acid oxidase prevents retinal neurovascular pathologies in diabetic rats.
10/2018	Loss-of-function mutation of serine racemase attenuates retinal ganglion cell loss in diabetic mice.
11/2017	Serine racemase deficiency attenuates choroidal neovascularization and reduces nitric oxide and VEGF levels by retinal pigment epithelial cells.
1/2016	Loss-of-function mutation of serine racemase attenuates excitotoxicity by intravitreal injection of N-methyl-D-aspartate.
9/2011	Overexpression of serine racemase in retina and overproduction of D-serine in eyes of streptozotocin-induced diabetic retinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haiyan Jiang Research Topics

Disease

26	Neoplasms (Cancer) 05/2024 - 12/2010
16	Hemophilia A (Haemophilia) 01/2020 - 09/2003
10	Hemophilia B (Haemophilia B) 01/2016 - 03/2006
8	Inflammation (Inflammations) 01/2023 - 04/2011
8	Hearing Loss (Hearing Impairment) 01/2022 - 12/2011
6	Ototoxicity 01/2022 - 12/2002
6	Ovarian Neoplasms (Ovarian Cancer) 07/2020 - 05/2015
5	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 01/2015
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 07/2009
5	Sepsis (Septicemia) 10/2021 - 01/2018
5	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 09/2011
5	Carcinogenesis 01/2019 - 01/2011
5	Hemorrhage 05/2015 - 03/2012
4	Body Weight (Weight, Body) 05/2023 - 09/2011
4	Prostatic Neoplasms (Prostate Cancer) 03/2018 - 05/2015
3	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 07/2009
3	Carcinoma (Carcinomatosis) 05/2023 - 07/2014
3	Insulin Resistance 10/2022 - 10/2019
3	Wounds and Injuries (Trauma) 09/2022 - 12/2011
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 10/2014
3	Infections 04/2021 - 01/2005
3	Liver Diseases (Liver Disease) 01/2021 - 06/2010
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2019 - 04/2016
3	Neoplasm Metastasis (Metastasis) 01/2018 - 11/2013
3	Fatigue 02/2016 - 11/2013
3	Parkinson Disease (Parkinson's Disease) 03/2012 - 07/2009
2	Non-alcoholic Fatty Liver Disease 05/2024 - 10/2019
2	Breast Neoplasms (Breast Cancer) 05/2024 - 05/2015
2	Disease Progression 10/2023 - 04/2017
2	Spinal Cord Injuries (Spinal Cord Injury) 05/2022 - 11/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 11/2013
2	Diabetes Mellitus 01/2019 - 10/2018
2	Choroidal Neovascularization 01/2019 - 11/2017
2	Auditory neuropathy 01/2019 - 08/2012
2	Deafness (Deaf Mutism) 01/2019 - 12/2016
2	Nausea 04/2017 - 11/2013
2	Ovarian Epithelial Carcinoma 08/2015 - 05/2015
2	Glioblastoma (Glioblastoma Multiforme) 03/2014 - 03/2014
2	Multiple Myeloma 08/2013 - 06/2013
2	Genomic Instability 04/2011 - 12/2010
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2024
1	Thrombosis (Thrombus) 03/2024

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2003
12	Factor VIII (Coagulation Factor VIII)IBA 01/2020 - 09/2003
10	Biomarkers (Surrogate Marker)IBA 10/2023 - 04/2011
10	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2016 - 03/2006
6	serine racemaseIBA 01/2022 - 09/2011
6	factor VIII-Fc fusion proteinIBA 12/2015 - 03/2012
5	Retinaldehyde (Retinal)IBA 01/2021 - 01/2016
5	Serine (L-Serine)FDA Link 01/2021 - 09/2011
5	factor IX Fc fusion proteinIBA 01/2016 - 01/2012
4	Cisplatin (Platino)FDA LinkGeneric 02/2019 - 11/2011
4	Neutralizing AntibodiesIBA 01/2019 - 01/2005
4	Sirtuin 2IBA 01/2019 - 06/2012
4	Sirtuin 3IBA 01/2019 - 12/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2022 - 06/2013
3	MicroRNAs (MicroRNA)IBA 09/2022 - 09/2020
3	CholesterolIBA 01/2022 - 10/2020
3	CyclodextrinsIBA 01/2022 - 01/2021
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 08/2015
3	SirtuinsIBA 01/2019 - 01/2011
3	Temozolomide (Temodar)FDA LinkGeneric 05/2017 - 03/2014
3	Hemostatics (Antihemorrhagics)IBA 01/2014 - 01/2012
2	CarbohydratesIBA 05/2024 - 09/2020
2	fibrin fragment D (D-dimer)IBA 03/2024 - 05/2021
2	Insulin (Novolin)FDA Link 10/2022 - 09/2020
2	AntioxidantsIBA 09/2022 - 01/2022
2	LipidsIBA 01/2021 - 08/2007
2	Caspase 9IBA 01/2021 - 01/2010
2	Caspase 3 (Caspase-3)IBA 01/2021 - 01/2010
2	Blood Glucose (Blood Sugar)IBA 09/2020 - 09/2011
2	LigandsIBA 03/2020 - 04/2011
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2018 - 10/2017
2	AntibodiesIBA 01/2017 - 03/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 01/2011
2	Cadherins (E-Cadherin)IBA 01/2017 - 10/2014
2	Ethacrynic Acid (Etacrynic Acid)FDA Link 12/2016 - 12/2002
2	DiureticsIBA 12/2016 - 11/2011
2	Furosemide (Lasix)FDA LinkGeneric 12/2016 - 11/2011
2	Mefloquine (Lariam)FDA LinkGeneric 01/2013 - 07/2011
2	Superoxides (Superoxide)IBA 01/2011 - 12/2010
2	ManganeseIBA 07/2009 - 07/2009
1	RNA (Ribonucleic Acid)IBA 05/2024
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 05/2024
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 05/2024
1	Stearoyl-CoA DesaturaseIBA 05/2024
1	CeramidesIBA 05/2024
1	Carrier Proteins (Binding Protein)IBA 05/2024
1	lysophosphatidylethanolamineIBA 05/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2024
1	cupric sulfide (CuS)IBA 03/2024

Therapy/Procedure

21	Therapeutics 11/2023 - 01/2005
10	Radiotherapy 01/2018 - 01/2011
8	Drug Therapy (Chemotherapy) 05/2023 - 01/2011
2	Aftercare (After-Treatment) 05/2024 - 09/2015
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2023 - 01/2023
2	Intraperitoneal Injections 01/2022 - 09/2011
2	Brachytherapy 03/2019 - 09/2017
2	Intravenous Injections 01/2019 - 03/2012
1	Cesarean Section (Caesarean Section) 03/2024